EVALUATION OF PUVASOL AND PUVASOL WITH TOPICAL BETAMETHASONE DIPROPIONATE PLUS SALICYLIC ACID LOTION IN THE TREATMENT...

Area of Science:

• Dermatology
• Pharmacology

Background:

• Scalp psoriasis is a common chronic skin condition.
• Existing treatments have varying efficacy and side effect profiles.

Purpose of the Study:

• To evaluate the efficacy and safety of betamethasone dipropionate 0.05% with salicylic acid 2% scalp lotion combined with PUVASOL for moderate to severe scalp psoriasis.
• To compare the combination therapy against PUVASOL monotherapy.

Main Methods:

• A study involving 120 patients with scalp psoriasis.
• 60 patients received PUVASOL alone, while 60 received PUVASOL plus the betamethasone dipropionate-salicylic acid lotion for 3 weeks.

Main Results:

• The combination therapy demonstrated significant improvement in erythema, induration, scales, and pruritus.
• 84.3% of patients on combination therapy achieved 75% improvement versus 34.9% on PUVASOL alone.
• Complete scalp clearing was observed in 35% with combination therapy compared to 11.6% with PUVASOL alone.

Conclusions:

• Combined therapy with PUVASOL and topical betamethasone dipropionate 0.05% with salicylic acid 2% is a safe and effective treatment for scalp psoriasis.
• The combination therapy offers superior outcomes compared to PUVASOL monotherapy.